Capital Fund Management (CFM)’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15,501
| Closed | -$281K | – | 927 |
|
|
2025
Q1 | $281K | Sell |
15,501
-19,818
| -56% | -$360K | ﹤0.01% | 740 |
|
|
2024
Q4 | $893K | Sell |
35,319
-548
| -2% | -$13.8K | ﹤0.01% | 684 |
|
|
2024
Q3 | $1.22M | Sell |
35,867
-8,578
| -19% | -$292K | ﹤0.01% | 575 |
|
|
2024
Q2 | $1.64M | Buy |
+44,445
| New | +$1.64M | ﹤0.01% | 517 |
|
|
2015
Q3 | – | Sell |
-647
| Closed | -$245K | – | 690 |
|
|
2015
Q2 | $245K | Buy |
+647
| New | +$245K | ﹤0.01% | 601 |
|
|
2015
Q1 | – | Sell |
-1,501
| Closed | -$411K | – | 704 |
|
|
2014
Q4 | $411K | Buy |
+1,501
| New | +$411K | ﹤0.01% | 549 |
|
|
2014
Q2 | – | Sell |
-20,441
| Closed | -$5.42M | – | 797 |
|
|
2014
Q1 | $5.42M | Sell |
20,441
-16,062
| -44% | -$4.26M | 0.07% | 161 |
|
|
2013
Q4 | $13.3M | Buy |
36,503
+32,230
| +754% | +$11.7M | 0.16% | 72 |
|
|
2013
Q3 | $2.27M | Buy |
+4,273
| New | +$2.27M | 0.03% | 294 |
|